Valuation: Southern Acids (M)

Market Cap 433M 106M 93.2M 88.03M 80.22M 150M 10.18B 151M 1.05B 408M 5.2B 399M 390M 16.71B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value 6.25M 1.53M 1.35M 1.27M 1.16M 2.17M 147M 2.18M 15.2M 5.89M 75.07M 5.76M 5.63M 241M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
09-08 Southern Acids (M) Berhad Reports Group Production Results for the Month of August 2026 CI
08-28 Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Non Independent and Non Executive Director, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Appointment of Dato' Sri Dr Low Kok Thye as Acting Chairman, Effective August 28, 2026 CI
08-26 Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
08-13 Southern Acids (M) Berhad Reports Group Production Results for the Month of July 2026 CI
08-05 Southern Acids (M) Berhad Announces Redesignation of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie from Independent Director to Non-Independent Director, Effective August 5, 2026 CI
07-27 Southern Acids (M) Berhad Announces Single Tier Final Dividend on Ordinary Share for Financial Year Ending March 31, 2027, Payable on 11 November 2026 CI
07-14 Southern Acids (M) Berhad Reports Group Production Results for the Month of June 2026 CI
06-16 Southern Acids (M) Berhad Reports Group Production Results for the Month of May 2026 CI
05-22 Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended 31 March 2026 CI
05-22 Southern Acids (M) Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
1 day-1.90%
1 week-1.90%
Current month+0.32%
1 month+0.32%
3 months+2.31%
6 months+2.31%
Current year-2.52%
1 week 3.1
Extreme 3.1
3.18
1 month 3.05
Extreme 3.05
3.18
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 46 14/07/2015
Director of Finance/CFO 58 30/09/2013
Chief Tech/Sci/R&D Officer 38 15/07/2014
Director TitleAgeSince
Director/Board Member 66 09/08/2005
Director/Board Member 59 19/03/2012
Director/Board Member 58 26/03/2023
Change 5-day change 1-year change 3-year change Capi.($)
-1.90%-1.90%-8.28%-8.01% 106M
-1.11%-8.42%-11.27%+343.47% 4.56B
+1.76%-4.72%+39.93%+135.61% 1.92B
-2.92%-0.58%+14.70%+103.96% 934M
-2.83%-3.01%+4.93%+21.32% 594M
+2.27%+1.04%+26.54%+121.97% 557M
-1.83%-3.39%-20.26%-21.94% 462M
-0.75%-0.14%+8.77%+15.44% 424M
-2.60%+0.86%+61.31%+15.45% 410M
+0.42%+0.60%+9.65%+30.75% 298M
Average -0.98%-1.43%+12.60%+75.80% 1.03B
Weighted average by Cap. -0.75%-4.72%+7.62%+196.36%

Financials

2025 2026
Net sales 1.11B 271M 238M 225M 205M 384M 26.02B 387M 2.69B 1.04B 13.29B 1.02B 997M 42.72B 934M 229M 201M 190M 173M 324M 21.96B 326M 2.27B 880M 11.22B 860M 842M 36.06B
Net income 36.7M 9.01M 7.91M 7.47M 6.8M 12.74M 863M 12.83M 89.34M 34.6M 441M 33.82M 33.09M 1.42B 37.38M 9.17M 8.05M 7.6M 6.93M 12.97M 879M 13.06M 90.99M 35.24M 449M 34.45M 33.7M 1.44B
Net Debt -367M -90.05M -79.02M -74.63M -68.01M -127M -8.63B -128M -893M -346M -4.41B -338M -331M -14.17B -426M -105M -91.86M -86.75M -79.06M -148M -10.03B -149M -1.04B -402M -5.13B -393M -385M -16.47B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
28/09/26 MYR 3.100 -1.90% 7,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock